Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series studyNorazida Ab Rahman, Kalaiarasu M. Peariasamy, Ming Tsuey Lim et al.|Vaccine|2022Cited by 41
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in MalaysiaSu Lan Yang, Kalaiarasu M. Peariasamy, Avinash Kumar Chand et al.|Emerging Microbes & Infections|2022Cited by 27
Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in MalaysiaYuan Liang Woon, Pik Pin Goh, Yee Leng Lee et al.|The Lancet Regional Health - Western Pacific|2021Cited by 23
Serology surveillance of anti-SARS-CoV-2 antibodies among asymptomatic healthcare workers in Malaysian healthcare facilities designated for COVID-19 careYuan Liang Woon, Pik Pin Goh, Yee Leng Lee et al.|Unknown|2020Cited by 10
Time from last immunity event against infection during Omicron-dominant period in MalaysiaSu Lan Yang, Kalaiarasu M. Peariasamy, Adiratna Mat Ripen et al.|International Journal of Infectious Diseases|2022Cited by 6